Abstract
The chief aim of all medical, potentially curative follow-up care measures (recurrence prophylaxis, early detection and therapy of disease recurrence) is to lengthen survival time (fig. 1.3). The cancer disease thus represents the focus of curative follow-up care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliographie
— Amarenco G, Chantraine A (edit) (2006) Les fonctions sphinctériennes. Springer Paris
— Aspinal F, Hughes R, Higginson I et al. (2002) A user’s guide to the palliative care outcome scale. Palliative care & policy publications. Kings College, London
— Barat M, Franchignoni F (2004) Assessment in physical medicine and rehabilitation. Maugeri Foundation Books, PI-ME Press Pavia
— Bartsch HH, Delbrück H, Kruck P et al. (2000) Zur Prozessqualität in der onkologischen Rehabilitation. Rehabilitation 39; 355–8
— Bamias A, Kastritis E, Bamias C (2005) Osteonecrosis of the jaw in cancer after treatment with bisphophonates: Incidence and risk factors J Clin Oncol 23,34: 8580–7
— Barton D, Loprinzi CL (2004) Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clin J Oncol Nurs 8,1: 39–42
— Bausewein C, Fegg M, Radbruch L et al. (2005) Validation and clinical application of the German version of the palliative care outcome. J Pain Symptom Manage 30: 51–62
— Bradley C, Oberst K, Schenk M (2006) Absenteeism from work: The experience of employed breast and prostate cancer patients in the months following diagnosis. Psychooncology 15,8: 739–47
— Bundesarbeitsgemeinschaft für Rehabilitation (BAR) (2004) Rahmenempfehlungen zur ambulanten onkologischen Rehabilitation. Schriftenreihe der Bundesarbeitsgemeinschaft für Rehabilitation, Frankfurt
— Caliendo MD, Lee E, Queiroz R et al. (2001) Sclerotherapy with Use of Doxycycline after Percutaneous Drainage of Postoperative Lymphoceles. Journal of Vascular and Interventional Radiology 12: 73–7
— Carlsson C, Baigi A, Killander D et al. (2005) Motives for becoming and remaining member of patient associations. Support Care Cancer 20
— Charlson M, Pompei P, Ales K et al. (1987) A new method for classifying prognostic comorbity in longitudinal studies. J Chronic Dis, 40: 373–83
— Chen A, Petrylak D (2004) Complications of Androgen Deprivation Therapy in Men with Prostate Cancer. Current Oncology Reports 2004, 6: 209–15
— Dahn JR, Penedo FJ, Gonzalez JS et al. (2004) Sexual functioning and quality of life after prostate cancer treatment: Considering sexual desire. Urology 63,2: 273–7
— Delbrück H, Schmid L, Bartsch H et al. (2000) Zur Ergebnisqualität in der onkologischen Rehabilitation. Rehabilitation 39: 359–62
— Ershler N (2003) Cancer: A disease of the elderly. J support Oncol 1,2: 5–10
— Esper P, Redman BG (1999) Supportive care, pain management and quality of life in advanced prostate cancer. Urol Clin North Am 26: 375
— Finlay IG, Mason M, Shelley M (2005) Radioisotopes for the palliation of metastatic bone cancer: A systematic review. Lancet Oncol 6,6: 392–400
— Gilligan T, Kantoff P (2002) Chemotherapy for prostate cancer. Urology 60(suppl. 3A): 94–100
— Gray RE, Klotz LH (2004) Restoring sexual function in prostate cancer patients: An innovative approach. Can J Urol 11,3: 2285–9
— Gontero P, Fontana F, Bagnasacco A et al. (2003) Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urology 169: 2166–9
— Haab, F, Trockman B, Zimmern P et al. (1997) Quality of life and continence assessment of the artificial urinary sphincter in men with minimum 3.5 years of follow-up. J Urology 158: 435–9
— Hamdy NA, Papapoulos SE (2001) The palliative management of skeletal metastases in prostate cancer: Use of bone-seeking radionuclides and bisphosphonates
— Hartsell WF, Scott CB, Brunner DW et al. (2005) Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97,11: 798–804
— Key TJ et al. (2004) Fruits and vegetables and prostate cancer: No association among 1104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 109: 119–124
— Krupski T, Smith MR, Lee WC et al. (2004) Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer 101,3: 541–9
— Lawton CA, Won M, Pilepich M et al. (1991) Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 21: 935–9
— Lilleby W, Fossa SD, Waehre HR et al. (1999) Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 1,43, 4: 735–43
— Mason T (2005) Information needs of wives of men following prostatectomy. Oncol Nurs Forum 10,32, 3: 557–63
— Mathewson-Chapman M (1997) Pelvic muscle exercise/biofeedback for urinary incontinence after prostatectomy: An education program. J Cancer Educ 12,4: 218–23
— McEwan AJ (2000) Use of radionuclides for the palliation of bone metastases. Semin Radiat Oncol 10,2: 103–14
— McGlynn B, Al-Saffar N, Begg H et al. (2004) Management of urinary incontinence following radical prostatectomy. Urol Nurse 24,6: 475–82
— Montorsi F, Salonia A, Briganti A et al. (2005) Vardenifil for the treatment of erectile dysfunction: A critical review of the literature based on a personal clinical experience. Eur Urol 47,5: 612–21
— Nishimura K, Yamaguchi Y, Yamanaka M et al. (2005) Climacteric-Like Disorders in Prostate Cancer Patients Treated with LHRH Agonists. Arch of Andrology 51,1: 41–8
— Nilsson S, Strang P, Ginman C et al. (2005) Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. J Pain Symptom Manage 29,4: 352–7
— Pepper R, Pati J, Kaisary A (2004) The incidence and treatment of lymphoceles after radical retropubic prostatectomy: BJU International 95: 772–5
— Pisansky T (2005) External Beam Radiotherapy as Curative Treatment of Prostate Cancer. Mayo Clin Proc 80: 883–98
— Pomfret I, Haslam J (2002) To exercise or not to exercise? Journal of Community Nursing 16: 08
— Potosky AL, Legler J, Albertsen PC et al. (2000) Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the prostate cancer outcomes study. J Natl Cancer Inst 92: 1582–92
— Potosky AL, Davis WW, Hoffman RM et al. (2004) Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The Prostate Cancer Outcomes Study. J Natl Cancer Inst 96: 1358–67
— Prezioso D, Piccirillo G, Galasso R et al. Gynecomastia due to hormonte therapy for advanced prostate cancer. Tumouri 90,4: 410–5
— Riechers FA (2004) Including partners into the diagnosis of prostate cancer: a review of the literature to provide a model of care. Urol Nurse 24,1: 22–9
— Roth AJ, Rosenfeld B, Kornblith AB et al. (2003) The memorial anxiety scale for prostate cancer: Validation of a new scale to measure anxiety in men with prostate cancer. Cancer 97,11: 2910–8
— Roth A (2005) Improving Quality of Life: Psychiatric Aspects of Treating Prostate Cancer. Psychiatric Times Vol. XXII: 5
— Saad F, Gleason DM et al. (2004) Long term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Inst 96: 879–82
— Schmid L, Delbrück H, Bartsch H et al. (2000) Zur Strukturqualität in der onkologischen Rehabilitation. Rehabilitation, 39: 350–4
— Schover LR (2005) Sexuality and fertility after cancer. Hematology 1: 523
— Shahininan et al. (2005) N Engl J Med 352: 154–64
— Smith JJ, Barrett D (2002) Implantation of the artificial genito-urinary sphincter. In PC Walsh et al., eds., Campbell’s Urology, 8th ed., 2: 1187–94. Philadelphia: WB. Saunders.
— Smith M et al. (2003) Randomised controlled trial of zolendronic acid to prevent boneloss in men receiving androgen deprivation therapy for non metastatic prostate cancer. The Journal of Urology, 169: 2008–12
— Stoeckli R, Keller U (2004) Nutritional fat and the risk of type 2 diabetes and cancer. Physiol Behav 83,4: 611–5
— Tanvetyanon T (2005) Long-term efficacy of zoledronic acid fort he prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 5,97, 1: 70–1
— Yablon CM, Banner MP, Ramchandani P et al. (2004) Complications of prostate cancer treatment: Spectrum of imaging findings. Radiographics 24,suppl. 1: 181–94
— Yi Su, Davis B, Herman M et al. (2004) Prostate brachytherapy seed localization by analysis of multiple projections: Identifying and addressing the seed overlap problem. Medical Physics 31,5: 1277–87
— Van Kampen M, de Weerdt W, van Poppel H et al. (2000) Effect of pelvic-floor reeducation on duration and degree of incontinence after radical prostatectomy: A randomized controlled trial. Lancet 355: 98–102
— Watson T, Mock V (2004) Exercise as an intervention for cancer-related fatigue. Phys Ther 84: 736–43
— Walsh PC, Marschke P, Ricker D et al. (2000) Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 55(1): 58–61
— Ward JF, Blute ML, Slezak J et al. (2003) The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 170: 1872–6
— William K (2000) Chemotherapy for patients with advanced prostate carcinoma. A new option for therapy. Cancer 88: 3015–21
— Windsor PM, Nicol KF, Potter J (2004) A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma Cancer, 101,3: 550–7
— Zaak D, Hungerhuber E, Müller-Lisse U et al. (2003) Urological emergencies. Urologe (A) 42: 849–63
— Zeegers MP, Friesema IH, Goldbohm RA et al. (2004) A prospective study of occupation and prostate cancer risk. J Occup Environ Med 46,3: 271–9
Rights and permissions
Copyright information
© 2007 Springer-Verlag France, Paris
About this chapter
Cite this chapter
(2007). Rehabilitation and palliation of patients with prostatic cancer. In: Rehabilitation and palliation of cancer patients. Collection de L’Académie Européenne de Médecine de Réadaptation. Springer, Paris. https://doi.org/10.1007/978-2-287-72827-3_13
Download citation
DOI: https://doi.org/10.1007/978-2-287-72827-3_13
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-72826-6
Online ISBN: 978-2-287-72827-3
eBook Packages: MedicineMedicine (R0)